The biotech sector has spent close to a year in no man's land. While technology, AI, and the broader market raced to new highs, biotechs have largely sat out the rally. But that may finally be changing. The sector is now setting up for what could be one of the most compelling multi-year breakouts in the market, and the technical picture is starting to confirm what the fundamentals have been hinting at for some time.
A simple way to track the sector is through the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB), which holds the largest and most influential names in the industry.
